anurajms/meta_analysis huggingface dataset:
Provide patient population that should be included in the study
Positive end‐expiratory pressure for preterm infants requiring conventional mechanical ventilation for respiratory distress syndrome or bronchopulmonary dysplasia
1. Bronchopulmonary Dysplasia Of Newborn 2. Birth to 1 mo 3. Neonatal Respiratory Distress Syndrome 4. Preterm Infant 5. Mechanical ventilation
Provide patient population that should be included in the study
Iodine supplementation for the prevention of mortality and adverse neurodevelopmental outcomes in preterm infants
1. Birth to 1 mo 2. Preterm Infant
Provide patient population that should be included in the study
Parenteral versus oral iron therapy for adults and children with chronic kidney disease
1. Child, Preschool 2-5 years 2. Adult 19-44 years 3. Child 6-12 years 4. Middle Aged 45-64 years 5. Anemia 6. Young Adult 19-24 years 7. Chronic Kidney Disease 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Education of family members to support weaning to solids and nutrition in infants born preterm
1. Adult 19-44 years 2. Premature Delivery 3. Middle Aged 45-64 years 4. Parent 5. Young Adult 19-24 years 6. Caregiver
Provide patient population that should be included in the study
Interventions for primary vesicoureteric reflux
1. Child, Preschool 2-5 years 2. Adult 19-44 years 3. Child 6-12 years 4. Middle Aged 45-64 years 5. Primary Vesicoureteric Reflux 6. Young Adult 19-24 years 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Antibiotic treatment for newborns with congenital syphilis
1. Congenital Syphilis 2. Birth to 1 mo
Provide patient population that should be included in the study
Dietary interventions for induction and maintenance of remission in inflammatory bowel disease
1. Child, Preschool 2-5 years 2. Adult 19-44 years 3. Child 6-12 years 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Inflammatory Bowel Disease 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Needle aspiration versus intercostal tube drainage for pneumothorax in the newborn
1. Pneumothorax 2. Neonate 3. Birth to 1 mo
Provide patient population that should be included in the study
Intermittent iron supplementation for reducing anaemia and its associated impairments in adolescent and adult menstruating women
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Adolescent 13-18 years
Provide patient population that should be included in the study
Phosphodiesterase 5 inhibitors for pulmonary hypertension
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Pulmonary Hypertension 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Pharmacotherapies for cannabis dependence
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Cannabis Dependence 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
School‐based self‐management interventions for asthma in children and adolescents: a mixed methods systematic review
1. Child 6-12 years 2. Adolescent 13-18 years 3. Asthma
Provide patient population that should be included in the study
Antibiotics for treating urogenital Chlamydia trachomatis infection in men and non‐pregnant women
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Not Pregnant 4. Middle Aged 45-64 years 5. Sexually Active 6. Young Adult 19-24 years 7. Aged 65-79 years 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Surgical versus conservative interventions for treating fractures of the middle third of the clavicle
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Child 6-12 years 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years 8. Clavicle fracture
Provide patient population that should be included in the study
Oral H1 antihistamines as ‘add‐on’ therapy to topical treatment for eczema
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Eczema 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Inpatient versus outpatient care, partial hospitalisation and waiting list for people with eating disorders
1. Child, Preschool 2-5 years 2. Adult 19-44 years 3. Child 6-12 years 4. Middle Aged 45-64 years 5. Eating Disorder 6. Young Adult 19-24 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Adverse events in people taking macrolide antibiotics versus placebo for any indication
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Aged 65-79 years 10. Adolescent 13-18 years
Provide patient population that should be included in the study
Adrenaline and vasopressin for cardiac arrest
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Cardiac Arrest 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Postoperative epidural analgesia versus systemic analgesia for thoraco‐lumbar spine surgery in children
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Birth to 1 mo 5. Adolescent 13-18 years 6. Surgical Spinal Manipulation
Provide patient population that should be included in the study
Antiamoebic drugs for treating amoebic colitis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Aged 65-79 years 10. Adolescent 13-18 years 11. Amebic Colitis
Provide patient population that should be included in the study
Potentiators (specific therapies for class III and IV mutations) for cystic fibrosis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Cystic Fibrosis 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Transfusion of red blood cells stored for shorter versus longer duration for all conditions
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Anemia 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Red Blood Cell Transfusion 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for treating wrist fractures in children
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Open Fracture Of Distal End Of Radius 4. Infant 1 to 23 mo 5. Fracture Of Distal End Of Radius 6. Open Fracture Of Lower End Of Forearm 7. Birth to 1 mo 8. Closed Fracture Of Lower End Of Forearm 9. Wrist Fracture 10. Adolescent 13-18 years
Provide patient population that should be included in the study
First aid interventions by laypeople for acute oral poisoning
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Poisoning 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Sedation of children undergoing dental treatment
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Birth to 1 mo 5. Dental anxiety 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Short‐acting insulin analogues versus regular human insulin for adult, non‐pregnant persons with type 2 diabetes mellitus
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Type 2 Diabetes Mellitus 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Maternal probiotic supplementation for prevention of morbidity and mortality in preterm infants
1. Adult 19-44 years 2. Premature Delivery 3. Young Adult 19-24 years 4. Pregnancy 5. Birth to 1 mo 6. Preterm Infant 7. Mother Delivered 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Liberal versus conservative fluid therapy in adults and children with sepsis or septic shock
1. Child, Preschool 2-5 years 2. Adult 19-44 years 3. Child 6-12 years 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Sepsis 7. Septic Shock 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Dressings and topical agents for preventing pressure ulcers
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Pressure ulcer 8. Young Adult 19-24 years 9. Birth to 1 mo 10. At Risk Of Disease 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Oral and intrauterine progestogens for atypical endometrial hyperplasia
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Atypical Endometrial Hyperplasia 6. Aged 65-79 years
Provide patient population that should be included in the study
Inhaled steroids with and without regular salmeterol for asthma: serious adverse events
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Aged 65-79 years 10. Adolescent 13-18 years 11. Asthma
Provide patient population that should be included in the study
Laparoscopic versus open surgery for suspected appendicitis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Acute Appendicitis 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Oral isotretinoin for acne
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Acne 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Omega‐3 fatty acid addition during pregnancy
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Phonics training for English‐speaking poor readers
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Difficulty Reading 4. Adolescent 13-18 years
Provide patient population that should be included in the study
Protocol‐directed sedation versus non‐protocol‐directed sedation in mechanically ventilated intensive care adults and children
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Critical Illness 9. Birth to 1 mo 10. Mechanical ventilation 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Communication interventions for autism spectrum disorder in minimally verbal children
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Minimally Verbal 4. Autism Spectrum Disorder 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Caseworker‐assigned discharge plans to prevent hospital readmission for acute exacerbations in children with chronic respiratory illness
1. Child, Preschool 2-5 years 2. Acute Exacerbation Of Bronchiectasis 3. Child 6-12 years 4. Hospital discharge 5. Infant 1 to 23 mo 6. Acute Asthma 7. Acute Exacerbation Of Chronic Bronchitis 8. Birth to 1 mo 9. Hospitalization 10. Adolescent 13-18 years
Provide patient population that should be included in the study
One‐to‐one oral hygiene advice provided in a dental setting for oral health
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Aged 65-79 years 10. Adolescent 13-18 years
Provide patient population that should be included in the study
Biocompatible dialysis fluids for peritoneal dialysis
1. Child, Preschool 2-5 years 2. Adult 19-44 years 3. Child 6-12 years 4. Middle Aged 45-64 years 5. Peritoneal Dialysis 6. Young Adult 19-24 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Child 6-12 years 4. Infant 1 to 23 mo 5. Tonic-clonic Seizure 6. Epilepsy 7. Aged 65-79 years 8. Adolescent 13-18 years 9. Adult 19-44 years 10. Partial Seizure 11. Middle Aged 45-64 years 12. Young Adult 19-24 years 13. Birth to 1 mo
Provide patient population that should be included in the study
Oxcarbazepine versus phenytoin monotherapy for epilepsy: an individual participant data review
1. Child, Preschool 2-5 years 2. Adult 19-44 years 3. Child 6-12 years 4. Middle Aged 45-64 years 5. Epilepsy 6. Young Adult 19-24 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Leukotriene receptor antagonists for eczema
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Eczema 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for preventing and treating cardiac complications in Duchenne and Becker muscular dystrophy and X‐linked dilated cardiomyopathy
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Child 6-12 years 4. Cardiac Complication 5. Infant 1 to 23 mo 6. Aged 65-79 years 7. Adolescent 13-18 years 8. Dilated Cardiomyopathy 9. Adult 19-44 years 10. Middle Aged 45-64 years 11. Young Adult 19-24 years 12. Birth to 1 mo 13. Becker Muscular Dystrophy 14. Duchenne Muscular Dystrophy 15. X-linked Hereditary Disease 16. Duchenne Muscular Dystrophy-associated Dilated Cardiomyopathy
Provide patient population that should be included in the study
Parent‐mediated interventions for promoting communication and language development in young children with Down syndrome
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Birth to 1 mo 5. Down syndrome
Provide patient population that should be included in the study
Dietary modifications for infantile colic
1. Infant 1 to 23 mo 2. Infantile Colic 3. Breast Fed 4. Bottle fed
Provide patient population that should be included in the study
Eszopiclone for insomnia
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Insomnia 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Psychological interventions for needle‐related procedural pain and distress in children and adolescents
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Procedural Pain 4. Young Adult 19-24 years 5. Needle Stick/puncture 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Pregnancy 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Psychological therapies for the management of chronic and recurrent pain in children and adolescents
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Headache 4. Infant 1 to 23 mo 5. Birth to 1 mo 6. Adolescent 13-18 years 7. Chronic Pain
Provide patient population that should be included in the study
Antibiotics for treating scrub typhus
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Scrub Typhus 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Insulin and glucose‐lowering agents for treating people with diabetes and chronic kidney disease
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Chronic Kidney Disease 10. Diabetes Mellitus 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Topical and systemic antifungal therapy for chronic rhinosinusitis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Chronic Rhinosinusitis 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years 12. Polyps Nasal
Provide patient population that should be included in the study
Oropharyngeal colostrum in preventing mortality and morbidity in preterm infants
1. Birth to 1 mo 2. Intensive Care 3. Preterm Infant
Provide patient population that should be included in the study
Head‐to‐head trials of antibiotics for bronchiectasis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Bronchiectasis 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Autologous cells derived from different sources and administered using different regimens for 'no‐option' critical lower limb ischaemia patients
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Critical Lower Limb Ischemia 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Impact of medication reconciliation for improving transitions of care
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Aged 65-79 years 10. Adolescent 13-18 years
Provide patient population that should be included in the study
Drugs for treating Buruli ulcer (Mycobacterium ulcerans disease)
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Buruli Ulcer 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Client feedback in psychological therapy for children and adolescents with mental health problems
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Mental disorder 4. Adolescent 13-18 years
Provide patient population that should be included in the study
Xenon as an adjuvant to therapeutic hypothermia in near‐term and term newborns with hypoxic‐ischaemic encephalopathy
1. Neonate 2. Birth to 1 mo 3. Brain disorder 4. Perinatal Asphyxia 5. Late Preterm Infant (34-36 weeks)
Provide patient population that should be included in the study
E‐Health interventions for anxiety and depression in children and adolescents with long‐term physical conditions
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Birth to 1 mo 5. Depression 6. Anxiety 7. Chronic Disease 8. Adolescent 13-18 years
Provide patient population that should be included in the study
Enteral nutrition for maintenance of remission in Crohn's disease
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Gastrointestinal Crohn's Disease 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Sodium valproate versus phenytoin monotherapy for epilepsy: an individual participant data review
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Partial Seizure 6. Middle Aged 45-64 years 7. Epilepsy 8. Young Adult 19-24 years 9. Aged 65-79 years 10. Adolescent 13-18 years
Provide patient population that should be included in the study
Needle size for vaccination procedures in children and adolescents
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Vaccination 5. Young Adult 19-24 years 6. Birth to 1 mo 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Vitamin A and beta (β)‐carotene supplementation for cystic fibrosis
1. Child, Preschool 2-5 years 2. Adult 19-44 years 3. Child 6-12 years 4. Middle Aged 45-64 years 5. Infant 1 to 23 mo 6. Cystic Fibrosis 7. Young Adult 19-24 years 8. Pancreatic Insufficiency 9. Birth to 1 mo 10. Adolescent 13-18 years
Provide patient population that should be included in the study
Colloids versus crystalloids for fluid resuscitation in critically ill people
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Child 6-12 years 4. Infant 1 to 23 mo 5. Volume Replacement 6. Trauma 7. Aged 65-79 years 8. Adolescent 13-18 years 9. Burn 10. Adult 19-44 years 11. Middle Aged 45-64 years 12. Surgery 13. Young Adult 19-24 years 14. Illness 15. Birth to 1 mo 16. Complication 17. Sepsis
Provide patient population that should be included in the study
Antibiotics for prolonged wet cough in children
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Chronic Cough 4. Cough 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Treatment for chronic methicillin‐sensitive Staphylococcus aureus pulmonary infection in people with cystic fibrosis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Child 6-12 years 4. Infant 1 to 23 mo 5. Cystic Fibrosis 6. Aged 65-79 years 7. Infection due to Pseudomonas Aeruginosa 8. Adolescent 13-18 years 9. Adult 19-44 years 10. Middle Aged 45-64 years 11. Young Adult 19-24 years 12. Birth to 1 mo 13. Infection By Methicillin Sensitive Staphylococcus Aureus
Provide patient population that should be included in the study
Ear drops for the removal of ear wax
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Aged 65-79 years 10. Ear wax 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Parent‐mediated communication interventions for improving the communication skills of preschool children with non‐progressive motor disorders
1. Child, Preschool 2-5 years 2. Infant 1 to 23 mo 3. Motor Skill Disorder 4. Birth to 1 mo 5. Difficulty Communicating
Provide patient population that should be included in the study
Parent training interventions for parents with intellectual disability
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Parent 5. Young Adult 19-24 years 6. Caregiver 7. Intellectual Disability 8. Aged 65-79 years
Provide patient population that should be included in the study
Psychological therapies for the treatment of mental disorders in low‐ and middle‐income countries affected by humanitarian crises
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Mental disorder 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years 12. Crisis
Provide patient population that should be included in the study
Effects of total fat intake on bodyweight in children
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Adolescent 13-18 years
Provide patient population that should be included in the study
Negative pressure wound therapy for open traumatic wounds
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Laceration 4. Abrasion 5. Gunshot Wound 6. Avulsion - Injury 7. Stab Wound 8. Animal Bite Wound 9. Adolescent 13-18 years 10. Adult 19-44 years 11. Crushing Injury 12. Middle Aged 45-64 years 13. Puncture Wound - Injury 14. Young Adult 19-24 years 15. Penetrating Wound 16. Open Fracture 17. Degloving Injury
Provide patient population that should be included in the study
Antifibrinolytic therapy for preventing oral bleeding in people on anticoagulants undergoing minor oral surgery or dental extractions
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Procedure On Oral Cavity 10. Aged 65-79 years 11. Anticoagulant therapy 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Partial Seizure 6. Middle Aged 45-64 years 7. Infant 1 to 23 mo 8. Tonic-clonic Seizure 9. Young Adult 19-24 years 10. Birth to 1 mo 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Pharmacological treatment for attention deficit hyperactivity disorder (ADHD) in children with comorbid tic disorders
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Gilles De La Tourette's Syndrome 4. Attention Deficit Hyperactivity Disorder 5. Adolescent 13-18 years 6. Chronic Motor Or Vocal Tic Disorder
Provide patient population that should be included in the study
Antibiotics for exacerbations of asthma
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Emergency Care 6. Middle Aged 45-64 years 7. Infant 1 to 23 mo 8. Acute Asthma 9. Young Adult 19-24 years 10. Birth to 1 mo 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Early planned removal versus expectant management of peripherally inserted central catheters to prevent infection in newborn infants
1. Neonate 2. Birth to 1 mo 3. Peripherally Inserted Central Catheterization
Provide patient population that should be included in the study
Local anaesthetics and regional anaesthesia versus conventional analgesia for preventing persistent postoperative pain in adults and children
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Elective Surgery 6. Middle Aged 45-64 years 7. Infant 1 to 23 mo 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Nurse‐led versus doctor‐led care for bronchiectasis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Bronchiectasis 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Immunosuppressive drug therapy for preventing rejection following lung transplantation in cystic fibrosis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Child 6-12 years 4. Infant 1 to 23 mo 5. Cystic Fibrosis 6. Heart Transplant 7. Aged 65-79 years 8. Adolescent 13-18 years 9. Adult 19-44 years 10. Middle Aged 45-64 years 11. Young Adult 19-24 years 12. Transplant Of Lung 13. Birth to 1 mo
Provide patient population that should be included in the study
Dual antibiotics for bronchiectasis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Young Adult 19-24 years 7. Bronchiectasis 8. Aged 65-79 years 9. Adolescent 13-18 years
Provide patient population that should be included in the study
Ribavirin for treating Crimean Congo haemorrhagic fever
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Congo-Crimean haemorrhagic fever 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Continuous versus intermittent antibiotics for bronchiectasis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Bronchiectasis 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Intramuscular versus oral corticosteroids to reduce relapses following discharge from the emergency department for acute asthma
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Emergency Care 6. Middle Aged 45-64 years 7. Infant 1 to 23 mo 8. Acute Asthma 9. Young Adult 19-24 years 10. Birth to 1 mo 11. Aged 65-79 years 12. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for childhood apraxia of speech
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Childhood Apraxia Of Speech 4. Adolescent 13-18 years
Provide patient population that should be included in the study
Neuromuscular electrostimulation for adults with chronic obstructive pulmonary disease
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Young Adult 19-24 years 4. Chronic Obstructive Pulmonary Disease
Provide patient population that should be included in the study
Mirtazapine adjunct for people with schizophrenia
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Schizophrenic Related Disorders 6. Schizophrenia 7. Aged 65-79 years
Provide patient population that should be included in the study
Educational interventions for improving primary caregiver complementary feeding practices for children aged 24 months and under
1. Child, Preschool 2-5 years 2. Complementary Feeding 3. Infant 1 to 23 mo
Provide patient population that should be included in the study
Trihexyphenidyl for dystonia in cerebral palsy
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Aged 65-79 years 10. Dystonic Cerebral Palsy 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Cyclamen europaeum extract for acute sinusitis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Acute Sinusitis 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Grommets (ventilation tubes) for recurrent acute otitis media in children
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Adolescent 13-18 years 5. Recurrent Acute Otitis Media
Provide patient population that should be included in the study
Early intensive behavioral intervention (EIBI) for young children with autism spectrum disorders (ASD)
1. Child, Preschool 2-5 years 2. Infant 1 to 23 mo 3. Autism Spectrum Disorder
Provide patient population that should be included in the study
Lower versus higher oxygen concentrations titrated to target oxygen saturations during resuscitation of preterm infants at birth
1. Birth to 1 mo 2. Preterm Infant 3. Resuscitation
Provide patient population that should be included in the study
Cyclodestructive procedures for non‐refractory glaucoma
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Glaucoma 4. Adult 19-44 years 5. Child 6-12 years 6. Middle Aged 45-64 years 7. Infant 1 to 23 mo 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Smectite for acute infectious diarrhoea in children
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Diarrhoea infectious 5. Birth to 1 mo 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for infantile haemangiomas of the skin
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Hemangioma 4. Infant 1 to 23 mo 5. Birth to 1 mo 6. Strawberry Nevus Of Skin 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Honey for acute cough in children
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Acute Cough 4. Infant 1 to 23 mo 5. Upper Respiratory Infection 6. Adolescent 13-18 years
Provide patient population that should be included in the study
Glucocorticosteroid‐free versus glucocorticosteroid‐containing immunosuppression for liver transplanted patients
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Liver transplant 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Ivermectin and permethrin for treating scabies
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Scabies 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Enteral nutritional therapy for induction of remission in Crohn's disease
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Crohn's Disease 6. Middle Aged 45-64 years 7. Infant 1 to 23 mo 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Early intervention (mobilization or active exercise) for critically ill adults in the intensive care unit
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Critical Illness 6. Intensive Care 7. Mechanical ventilation 8. Aged 65-79 years
Provide patient population that should be included in the study
Oral versus inhaled antibiotics for bronchiectasis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Young Adult 19-24 years 7. Bronchiectasis 8. Aged 65-79 years 9. Adolescent 13-18 years
Provide patient population that should be included in the study
Nutritional supplements for patients being treated for active visceral leishmaniasis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Visceral Leishmaniasis 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Vascular access specialist teams for device insertion and prevention of failure
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Vascular System 4. Adult 19-44 years 5. Child 6-12 years 6. Middle Aged 45-64 years 7. Infant 1 to 23 mo 8. Young Adult 19-24 years 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Immunoglobulin for alloimmune hemolytic disease in neonates
1. Isoimmune Hemolytic Disease 2. Neonate 3. Hemolytic Jaundice 4. Birth to 1 mo
Provide patient population that should be included in the study
Laryngeal mask airway versus bag‐mask ventilation or endotracheal intubation for neonatal resuscitation
1. Term infant (37-41 weeks) 2. Intermittent Positive Pressure Breathing 3. Birth to 1 mo 4. Preterm Infant 5. Resuscitation
Provide patient population that should be included in the study
Macrolide antibiotics for bronchiectasis
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Bronchiectasis 9. Aged 65-79 years 10. Adolescent 13-18 years
Provide patient population that should be included in the study
Systemic corticosteroids for acute otitis media in children
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Birth to 1 mo 5. Acute Otitis Media 6. Adolescent 13-18 years
Provide patient population that should be included in the study
The Neonatal Behavioral Assessment Scale (NBAS) and Newborn Behavioral Observations (NBO) system for supporting caregivers and improving outcomes in caregivers and their infants
1. Infant 1 to 23 mo 2. Birth to 1 mo
Provide patient population that should be included in the study
Interventions for preventing high altitude illness: Part 2. Less commonly‐used drugs
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. High Altitude Illness 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Standard (head‐down tilt) versus modified (without head‐down tilt) postural drainage in infants and young children with cystic fibrosis
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Infant 1 to 23 mo 4. Cystic Fibrosis 5. Gastroesophageal Reflux Disease 6. Birth to 1 mo
Provide patient population that should be included in the study
Provision of respiratory support compared to no respiratory support before cord clamping for preterm infants
1. Birth to 1 mo 2. Placental Transfusion 3. Preterm Infant
Provide patient population that should be included in the study
Endovascular revascularisation versus conservative management for intermittent claudication
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Intermittent claudication 9. Birth to 1 mo 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Interventions for autumn exacerbations of asthma in children
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Seasonal Asthma 4. Adolescent 13-18 years 5. Asthma
Provide patient population that should be included in the study
Antibiotics at the time of removal of central venous catheter to reduce morbidity and mortality in newborn infants
1. Neonate 2. Removal Of Catheter 3. Birth to 1 mo 4. Central Venous Catheterisation
Provide patient population that should be included in the study
Higher versus lower amino acid intake in parenteral nutrition for newborn infants
1. Neonate 2. Birth to 1 mo 3. Parenteral nutrition 4. Intensive Care
Provide patient population that should be included in the study
Beta‐blockers for prevention and treatment of retinopathy of prematurity in preterm infants
1. Retinopathy Of Prematurity 2. Birth to 1 mo 3. Retinopathy Of Prematurity Stage 2 - Intraretinal Ridge 4. Preterm Infant 5. Retinopathy Of Prematurity Stage 1 - Demarcation Line
Provide patient population that should be included in the study
Physical activity, diet and other behavioural interventions for improving cognition and school achievement in children and adolescents with obesity or overweight
1. Child, Preschool 2-5 years 2. Child 6-12 years 3. Overweight In Childhood 4. Childhood Obesity 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Slow‐release fluoride devices for the control of dental decay
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Dental Caries 8. Young Adult 19-24 years 9. Aged 65-79 years 10. Adolescent 13-18 years
Provide patient population that should be included in the study
Prostaglandin E1 for maintaining ductal patency in neonates with ductal‐dependent cardiac lesions
1. Term infant (37-41 weeks) 2. Ductal-Dependent Cardiac Lesions 3. Birth to 1 mo 4. Late Preterm Infant (34-36 weeks)
Provide patient population that should be included in the study
Welfare‐to‐work interventions and their effects on the mental and physical health of lone parents and their children
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Aged 65-79 years 10. Adolescent 13-18 years 11. Single Parent Family
Provide patient population that should be included in the study
BIS monitoring versus clinical assessment for sedation in mechanically ventilated adults in the intensive care unit and its impact on clinical outcomes and resource utilization
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Intensive Care 6. Mechanical ventilation 7. Aged 65-79 years
Provide patient population that should be included in the study
Interventions to prevent hypothermia at birth in preterm and/or low birth weight infants
1. Birth to 1 mo 2. Low Birth Weight Infant 3. Preterm Infant
Provide patient population that should be included in the study
Oral vitamin D supplementation for adults with obesity undergoing bariatric surgery
1. Obesity 2. Bariatric surgery
Provide patient population that should be included in the study
Midwife continuity of care models versus other models of care for childbearing women
1. Adult 19-44 years 2. Pregnant 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Adolescent 13-18 years
Provide patient population that should be included in the study
Antioxidants for adults with chronic kidney disease
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Kidney transplant 4. Young Adult 19-24 years 5. Chronic Kidney Disease 6. Renal Dialysis
Provide patient population that should be included in the study
Synbiotics, prebiotics and probiotics for people with chronic kidney disease
1. Child, Preschool 2-5 years 2. Adult 19-44 years 3. Child 6-12 years 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Chronic Kidney Disease 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Antioxidant vitamin and mineral supplements for slowing the progression of age‐related macular degeneration
1. Aged 80 and over 80+ years 2. Middle Aged 45-64 years 3. Age-related Macular Degeneration 4. Aged 65-79 years
Provide patient population that should be included in the study
Dance movement therapy for dementia
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Aged 65-79 years 5. Dementia
Provide patient population that should be included in the study
Low glycaemic index or low glycaemic load diets for people with overweight or obesity
1. Obesity 2. Overweight
Provide patient population that should be included in the study
Serenoa repens for the treatment of lower urinary tract symptoms due to benign prostatic enlargement
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Benign prostatic hyperplasia 5. Lower urinary tract symptoms 6. Aged 65-79 years
Provide patient population that should be included in the study
Non‐Chinese herbal medicines for functional dyspepsia
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Indigestion 6. Aged 65-79 years
Provide patient population that should be included in the study
Antidepressants for smoking cessation
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Smoker 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Cephalic version by moxibustion for breech presentation
1. Single Pregnancy 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Breech Presentation 5. Young Adult 19-24 years 6. Pregnancy 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Caffeine dosing regimens in preterm infants with or at risk for apnea of prematurity
1. Apnea of prematurity 2. Infant 1 to 23 mo 3. Birth to 1 mo 4. Preterm Infant
Provide patient population that should be included in the study
The McKenzie method for (sub)acute non‐specific low back pain
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Non-specific low back pain 6. Aged 65-79 years
Provide patient population that should be included in the study
Ultrasound and shockwave therapy for acute fractures in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Traumatic fracture 6. Aged 65-79 years
Provide patient population that should be included in the study
Altered dietary salt intake for preventing diabetic kidney disease and its progression
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Type 2 Diabetes Mellitus 5. Young Adult 19-24 years 6. Type 1 Diabetes Mellitus 7. Aged 65-79 years
Provide patient population that should be included in the study
Yoga for chronic non‐specific low back pain
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Chronic Low Back Pain 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Ginkgo biloba for tinnitus
1. Child, Preschool 2-5 years 2. Aged 80 and over 80+ years 3. Adult 19-44 years 4. Child 6-12 years 5. Middle Aged 45-64 years 6. Infant 1 to 23 mo 7. Young Adult 19-24 years 8. Birth to 1 mo 9. Tinnitus 10. Aged 65-79 years 11. Adolescent 13-18 years
Provide patient population that should be included in the study
Upper limb exercise for arteriovenous fistula maturation in people requiring permanent haemodialysis access
1. Aged 80 and over 80+ years 2. Renal Failure 3. Adult 19-44 years 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Arteriovenous Fistula 7. Haemodialysis 8. Aged 65-79 years
Provide patient population that should be included in the study
Repetitive peripheral magnetic stimulation for impairment and disability in people after stroke
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Stroke 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Acupuncture for treating overactive bladder in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Young Adult 19-24 years 5. Overactive Bladder Syndrome 6. Aged 65-79 years
Provide patient population that should be included in the study
Listening to music for insomnia in adults
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Middle Aged 45-64 years 4. Insomnia 5. Young Adult 19-24 years 6. Aged 65-79 years
Provide patient population that should be included in the study
Marine‐derived n‐3 fatty acids therapy for stroke
1. Aged 80 and over 80+ years 2. Adult 19-44 years 3. Stroke 4. Middle Aged 45-64 years 5. Young Adult 19-24 years 6. Aged 65-79 years 7. Adolescent 13-18 years
Provide patient population that should be included in the study
Antioxidants for male subfertility
1. Adult 19-44 years 2. Middle Aged 45-64 years 3. Subfertility 4. Young Adult 19-24 years
Provide patient population that should be included in the study
Psychological treatments for depression and anxiety in dementia and mild cognitive impairment
1. Mild Cognitive Impairment 2. Dementia